Skip to main content
. 2017 Oct 4;8(55):94028–94039. doi: 10.18632/oncotarget.21522

Table 1. The viability of GC cells treated with different concentrations of DOX.

cell lines SGC7901 BGC KATO mkn45
IC50(μg/ml) 0.8146(0.7179 to 0.9112) 1.103(0.9786 to 1.227) 2.507(1.760 to 3.254) 3.025(2.205 to 3.845)

IC50 values show Doxorubicin concentration [μg/ml. mean (95% confidence intervals)].